BYETTA Approved For Expanded Use As First-Line Treatment For Type 2 Diabetes
Links shared publicly online about this topic.
- 1,637total visits
BYETTA Approved For Expanded Use As First-Line Treatment For Type 2 Diabetes
View full resource at medicalnewstoday.com
Tags: Diabetes Type 2 Medication, Diabetes Medication, Type 2 Diabetes, Drug, Pharma, FDA, Byetta, Eli Lilly and Company
Most Recently Shared on October 31, 2009 at 12:49 pm By:
BYETTA Approved For Expanded Use As First-Line Treatment For Type 2 Diabetes: Amylin Pharmaceuticals, Inc., (Na.. http://bit.ly/FO6jd
Also Shared By:
Expanded approval for Byetta; but also renal warning
theheart.org — “The FDA has issued a warning about exenatide the same day the agency approved its first-line use along with diet and exercise to improve glycemic control in patients with type 2 diabetes mellitus.” View full resource at theheart.org
Most Recently Shared on November 3, 2009 at 6:41 pm By:
heartwire: FDA expands exenatide use; warns of renal-failure risk http://bit.ly/O9Drq
Byetta Approved for Expanded Use as First-Line Treatment for Type 2 Diabetes
drugs.com — “Byetta (exenatide) is used to treat type 2 diabetes. Includes Byetta side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on November 3, 2009 at 12:18 am By:
Byetta Approved for Expanded Use as First-Line Treatment for Type 2 Diabetes - http://bit.ly/q10EZ
Byetta gains expanded indication for first-line treatment for type 2 diabetes - MPR
empr.com — “The FDA has approved Byetta (exenatide injection, from Amylin and Lilly), a GLP-1 receptor agonist, for use as monotherapy along with diet and exercise to improve glycemic control in adults with type 2 diabetes.” View full resource at empr.com
Most Recently Shared on November 2, 2009 at 2:25 pm By:
MPR News: Byetta gains expanded indication for first-line treatment for type 2 diabetes: The FDA has approved Byetta... http://bit.ly/4kc5TM
Eli Lilly and Company - BYETTA Approved for Expanded Use as First-Line Treatment for Type 2 Diabetes
newsroom.lilly.com — “Eli Lilly and Company - BYETTA Approved for Expanded Use as First-Line Treatment for Type 2 Diabetes” View full resource at newsroom.lilly.com
Most Recently Shared on November 1, 2009 at 3:10 pm By:
eyeonfda Pharma and Health Lawyer
BYETTA Approved for Expanded Use as First-Line Treatment for Type 2 Diabetes - http://bit.ly/3SxCxX
Advertisement
MNT Clinical Trials
@mnt_clinical
BYETTA Approved For Expanded Use As First-Line Treatment For Type 2 Diabetes: Amylin Pharmaceuticals, Inc., (Na.. http://bit.ly/FO6jd
1 year ago...